Structural Characterization of Cyclic Peptides using a Quadrupole Time-of-Flight Mass Spectrometer
Posters | 2019 | ShimadzuInstrumentation
Cyclic peptides represent an emerging class of therapeutics with enhanced in vivo stability and cell permeability. Accurate structural characterization is essential for understanding their bioactivity and ensuring quality control during drug development.
This work presents a comprehensive LC/Q-TOF MS method for the structural analysis of the cyclic peptide cyclosporin A. The goal was to achieve full sequence coverage and precise fragment assignment via high-resolution MS and MS/MS experiments.
Accurate mass measurement confirmed [M+H]+ at m/z 1202.8486 and [M+2H]2+ at m/z 601.9279 within ±1 ppm. MS/MS spectra provided fragmentation along a, b, c, x, y, and z series, with mass errors below 1 mDa. The combined analysis achieved 100 % coverage of the cyclosporin A structure. Supplementary MS3 experiments on an IT-TOF system corroborated the MS/MS assignments.
The method enables rapid and reliable sequencing of cyclic peptides, facilitating drug discovery, metabolite profiling, and quality assurance workflows. High mass accuracy simplifies spectral interpretation and reduces manual verification.
Emerging directions include integration with ion mobility for conformer separation, automated spectral annotation using advanced informatics, and extension of the workflow to other macrocyclic compounds and complex peptidomimetics.
The developed LC/Q-TOF MS approach delivers comprehensive structural insights into cyclosporin A using only high-resolution MS/MS data. It demonstrates a robust platform for the accurate sequencing of cyclic peptides in research and industrial settings.
Matsubara T, Inohana Y, Hirano I Structural Characterization of Cyclic Peptides using a Quadrupole Time-of-Flight Mass Spectrometer ASMS 2019 PO-CON1892E
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesProteomics
ManufacturerShimadzu
Summary
Significance of the Topic
Cyclic peptides represent an emerging class of therapeutics with enhanced in vivo stability and cell permeability. Accurate structural characterization is essential for understanding their bioactivity and ensuring quality control during drug development.
Objectives and Study Overview
This work presents a comprehensive LC/Q-TOF MS method for the structural analysis of the cyclic peptide cyclosporin A. The goal was to achieve full sequence coverage and precise fragment assignment via high-resolution MS and MS/MS experiments.
Applied Methodology and Instrumentation
- UHPLC system: Nexera X2 with Shim-pack GISS column (2.1×50 mm, 1.9 µm)
- Mobile phases: 0.1 % formic acid in water (A) and in acetonitrile (B); gradient from 60 to 95 % B
- Flow rate: 0.3 mL/min; column temperature: 50 °C; injection volume: 1 µL
- Mass spectrometer: LCMS-9030 Q-TOF with >30 000 resolution (FWHM), <1 ppm mass accuracy, 100 Hz acquisition rate
- Data analysis: ACD/MS Workbook Suite for formula prediction and fragment assignment
Main Results and Discussion
Accurate mass measurement confirmed [M+H]+ at m/z 1202.8486 and [M+2H]2+ at m/z 601.9279 within ±1 ppm. MS/MS spectra provided fragmentation along a, b, c, x, y, and z series, with mass errors below 1 mDa. The combined analysis achieved 100 % coverage of the cyclosporin A structure. Supplementary MS3 experiments on an IT-TOF system corroborated the MS/MS assignments.
Benefits and Practical Applications
The method enables rapid and reliable sequencing of cyclic peptides, facilitating drug discovery, metabolite profiling, and quality assurance workflows. High mass accuracy simplifies spectral interpretation and reduces manual verification.
Future Trends and Potential Applications
Emerging directions include integration with ion mobility for conformer separation, automated spectral annotation using advanced informatics, and extension of the workflow to other macrocyclic compounds and complex peptidomimetics.
Conclusion
The developed LC/Q-TOF MS approach delivers comprehensive structural insights into cyclosporin A using only high-resolution MS/MS data. It demonstrates a robust platform for the accurate sequencing of cyclic peptides in research and industrial settings.
References
Matsubara T, Inohana Y, Hirano I Structural Characterization of Cyclic Peptides using a Quadrupole Time-of-Flight Mass Spectrometer ASMS 2019 PO-CON1892E
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Shimadzu Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer LCMS-9030
2020|Shimadzu|Brochures and specifications
C146-E365C Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer LCMS-9030 Effortless Performance The LCMS-9030 quadrupole time-of-flight (Q-TOF) mass spectrometer integrates the world’ s fastest and most sensitive quadrupole technology with TOF architecture. A product of Shimadzu's engineering DNA, speed and effortless performance…
Key words
mma, mmaspectrum, spectrumetizolam, etizolamquadrupole, quadrupolemass, massflight, flightflighttube, flighttubeprobe, probemikros, mikroschromatograph, chromatographmicroflow, microflowshimadzu, shimadzuspectrometer, spectrometerspectra, spectravalinomycin
Shimadzu Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer LCMS-9030
2020|Shimadzu|Brochures and specifications
C146-E365B Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer LCMS-9030 Effortless Performance The LCMS-9030 quadrupole time-of-flight (Q-TOF) mass spectrometer integrates the world’ s fastest and most sensitive quadrupole technology with TOF architecture. A product of Shimadzu's engineering DNA, speed and effortless performance…
Key words
mma, mmaspectrum, spectrumflight, flightetizolam, etizolamquadrupole, quadrupolemass, massflighttube, flighttubeprobe, probemikros, mikroschromatograph, chromatographshimadzu, shimadzuspectrometer, spectrometerspectra, spectravalinomycin, valinomycinhydroxyetizolam
Simplified approach for structural elucidation and quantitation for pharmaceutical API and related impurities
2019|Shimadzu|Posters
PO-CON1878E Simplified approach for structural elucidation and quantitation for pharmaceutical API and related impurities ASMS 2019 TP 746 Purushottam Sutar, Anant Lohar, Ashutosh Shelar, Deepti Bhandarkar, Bhaumik Trivedi, Navin Devadiga, Rashi Kochhar, Shailendra Rane, Shailesh Damale, Ajit Datar, Pratap Rasam…
Key words
paracetamol, paracetamolelucidation, elucidationimpurities, impuritiesstructural, structuralapi, apirelated, relatedsimplified, simplifiedpharmaceutical, pharmaceuticalquantitation, quantitationimp, impapproach, approachimpurity, impuritymonoisotopic, monoisotopicmass, massexplore
Characterizing Antibody-Drug Conjugates and Assigning Drug Conjugation Sites
2017|Agilent Technologies|Applications
Characterizing Antibody-Drug Conjugates and Assigning Drug Conjugation Sites Using the Agilent 1290 Infinity II 2D-LC Solution Combined with the Agilent 6530 Quadrupole Time-of-Flight LC/MS System Application Note Biopharmaceuticals Authors Abstract Koen Sandra, Gerd Vanhoenacker, Antibody-drug conjugates (ADCs) are a promising…
Key words
conjugated, conjugatedantibody, antibodyrplc, rplcmmae, mmaeconjugation, conjugationbrentuximab, brentuximabdrug, drugpeptides, peptidesadcetris, adcetrisscdk, scdkherceptin, herceptinintrachain, intrachainkadcyla, kadcylainterchain, interchaindimension